# SynGen Inc.: Form D filings

SynGen Inc., a biotechnology company in Sacramento, CA, filed 15 Form D notices with the SEC between 2012 and 2017. The latest, on June 26, 2017, reports $400,000 sold of a $400,000 offering to 1 investor.

Find out what SynGen Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20SynGen%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=SynGen%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fsyngen-inc-1547876)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20SynGen%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=SynGen%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fsyngen-inc-1547876)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 100 HOWE AVENUE, SUITE 185N, Sacramento, CA, 95825
- Phone: (916) 706-0923
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2012
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1547876

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jun 26, 2017 | New notice | $400,000 | $400,000 | $0 | 1 | Jun 14, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1547876/000154787617000005/0001547876-17-000005-index.htm) |
| Apr 21, 2017 | New notice | $500,000 | $500,000 | $0 | 1 | Apr 18, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1547876/000154787617000004/0001547876-17-000004-index.htm) |
| Mar 24, 2017 | New notice | $500,000 | $500,000 | $0 | 1 | Mar 21, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1547876/000154787617000003/0001547876-17-000003-index.htm) |
| Feb 27, 2017 | New notice | $500,000 | $500,000 | $0 | 2 | Feb 21, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1547876/000154787617000002/0001547876-17-000002-index.htm) |
| Jan 19, 2017 | New notice | $500,000 | $500,000 | $0 | 2 | Jan 12, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1547876/000154787617000001/0001547876-17-000001-index.htm) |
| Nov 28, 2016 | New notice | $1,000,000 | $1,000,000 | $0 | 3 | Nov 14, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1547876/000154787616000006/0001547876-16-000006-index.htm) |
| Jul 26, 2016 | New notice | $2,000,000 | $1,000,000 | $1,000,000 | 3 | Jul 13, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1547876/000154787616000005/0001547876-16-000005-index.htm) |
| May 10, 2016 | New notice | $1,563,422 | $1,563,422 | $0 | 3 | Apr 26, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1547876/000154787616000004/0001547876-16-000004-index.htm) |
| Feb 10, 2016 | New notice | $2,000,000 | $2,000,000 | $0 | 2 | Jan 8, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1547876/000154787616000003/0001547876-16-000003-index.htm) |
| Jun 8, 2015 | New notice | $3,000,000 | $2,250,000 | $750,000 | 2 | Mar 25, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1547876/000154787615000002/0001547876-15-000002-index.htm) |
| Sep 22, 2014 | New notice | $4,000,000 | $2,000,000 | $2,000,000 | 2 | Sep 12, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1547876/000154787614000002/0001547876-14-000002-index.htm) |
| Jan 7, 2014 | New notice | Indefinite | $0 | Indefinite | 1 | Dec 27, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1547876/000154787614000001/0001547876-14-000001-index.htm) |
| Jul 10, 2013 | New notice | $3,000,000 | $1,000,000 | $2,000,000 | 2 | Jul 2, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1547876/000154787613000002/0001547876-13-000002-index.htm) |
| Jul 10, 2013 | Amendment | $5,000,000 | $2,000,000 | $3,000,000 | 2 | Apr 17, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1547876/000154787613000001/0001547876-13-000001-index.htm) |
| Apr 24, 2012 | New notice | $5,000,000 | $2,000,000 | $3,000,000 | 2 | Apr 17, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1547876/000154787612000001/0001547876-12-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Vic H. Schmitt | Director |  |
| Philip H. Coelho | Executive Officer |  |
| Chuck A. Novak | Executive Officer |  |
| George H. Barry | Director |  |
| Carl A. Goldfischer | Director |  |
| William H. Gerber | Executive Officer, Director |  |
| Woodrow A. Myers, Jr. | Director |  |

## Other biotechnology companies in California that filed recently

- [CARI Health, Inc.](https://specstream.ai/data/form-d/company/cari-health-inc-1930994) $280,000 · Nov 6, 2026
- [Ausel, Inc.](https://specstream.ai/data/form-d/company/ausel-inc-2124022) $120,000 · Nov 4, 2026
- [Trellis Bioscience, Inc.](https://specstream.ai/data/form-d/company/trellis-bioscience-inc-1162015) $9.1 million · Oct 29, 2026
- [BigHat Biosciences, Inc.](https://specstream.ai/data/form-d/company/bighat-biosciences-inc-1797256) $75.1 million · Oct 26, 2026
- [Theravie Pharma, Inc.](https://specstream.ai/data/form-d/company/theravie-pharma-inc-2160768) $750,000 · Oct 19, 2026
- [Adela, Inc.](https://specstream.ai/data/form-d/company/adela-inc-1852167) $12 million · Oct 19, 2026
- [Estuary Biotherapeutics, Inc.](https://specstream.ai/data/form-d/company/estuary-biotherapeutics-inc-2138862) $40.7 million · Oct 16, 2026
- [Renue Life Sciences, Inc.](https://specstream.ai/data/form-d/company/renue-life-sciences-inc-2158207) $250,000 · Oct 14, 2026
- [Tempest Therapeutics, Inc.](https://specstream.ai/data/form-d/company/tempest-therapeutics-inc-1544227) $7.5 million · Oct 14, 2026
- [Lionheart Health, Inc.](https://specstream.ai/data/form-d/company/lionheart-health-inc-2156758) $387,500 · Oct 7, 2026
- [Rakuten Medical, Inc.](https://specstream.ai/data/form-d/company/rakuten-medical-inc-1595215) $9 million · Oct 6, 2026
- [Zonaliz, Inc.](https://specstream.ai/data/form-d/company/zonaliz-inc-2157556) $2.5 million · Oct 5, 2026
- [Altay Therapeutics, Inc.](https://specstream.ai/data/form-d/company/altay-therapeutics-inc-2157551) $15.7 million · Oct 2, 2026
- [Sialia Therapeutics, Inc.](https://specstream.ai/data/form-d/company/sialia-therapeutics-inc-2156754) $1.5 million · Sep 29, 2026
- [Vetmab Biosciences, Inc.](https://specstream.ai/data/form-d/company/vetmab-biosciences-inc-1932050) $11.4 million · Sep 29, 2026

[Every Form D from the week of Jun 26, 2017](https://specstream.ai/data/form-d/week/2017-06-26) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what SynGen Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).